DP Poland PLC
LSE:DPP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DP Poland PLC
LSE:DPP
|
UK |
|
Zoono Group Ltd
ASX:ZNO
|
AU |
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
US |
|
B
|
Borgestad ASA
OSE:BOR
|
NO |
|
A
|
Albis Leasing AG
DUS:ALG
|
DE |
|
T
|
Talis Biomedical Corp
OTC:TLIS
|
US |
|
Crestchic PLC
LSE:LOAD
|
UK |
|
Ely Gold Royalties Inc
OTC:ELDCF
|
CA |
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
JP |
|
D
|
Dexcom Inc
XMUN:DC4
|
US |
|
Devro PLC
LSE:DVO
|
UK |
|
I
|
Interpublic Group of Companies Inc
SWB:IPG
|
US |
|
People.cn Co Ltd
SSE:603000
|
CN |
Wall St Price Targets
DPP Price Targets Summary
DP Poland PLC
According to Wall Street analysts, the average 1-year price target for
DPP is 14.28 GBX with a low forecast of 14.14 GBX and a high forecast of 14.7 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DPP's stock price target?
Price Target
14.28
GBX
According to Wall Street analysts, the average 1-year price target for
DPP is 14.28 GBX with a low forecast of 14.14 GBX and a high forecast of 14.7 GBX.
What is the Revenue forecast for DP Poland PLC?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for DP Poland PLC?
Projected CAGR
1 014%
The compound annual growth rate for Operating Income over the next 2 years is 1 014%.